Scopely
Scopely Raises $340M in Debt
Scopely Raises $340M in Debt
Scopely has successfully raised $340M in a Debt led by TPG Capital.
Company Overview
Scopely is a Gaming company headquartered in Culver City, CA, founded in 2011 with 1000+ employees.
Mobile games developer
Fundraising Details
- Amount Raised: $340M
- Round Type: Debt
- Date: 2024-04-18
- Investors: TPG Capital
About Scopely
Mobile games developer The company is positioned in the Gaming sector, serving a growing market with innovative solutions.
Key Information
- Headquarters: Culver City, CA
- Founded: 2011
- Team Size: 1000+
- Industry: Gaming
What This Means
This funding round demonstrates strong investor confidence in Scopely's vision and execution. The capital will likely be used to:
- Scale Operations: Expand the team and operational capacity
- Product Development: Enhance existing products and develop new features
- Market Expansion: Enter new markets and strengthen presence in existing ones
- Technology Investment: Invest in infrastructure and technology capabilities
Industry Context
The Gaming sector continues to attract significant investment as companies innovate to meet evolving market demands. Scopely's successful fundraising reflects the strong fundamentals and growth potential in this space.
Looking Ahead
With this new capital, Scopely is well-positioned to execute on its growth strategy and continue building innovative solutions in the Gaming space. The company's trajectory will be one to watch as it deploys this funding to achieve its next phase of growth.
This fundraising news was reported on 2024-04-18. For more information about Scopely, visit their headquarters at Culver City, CA.
Company Info
Share
Related Reports
Tebra Raises $250M Growth Financing | Healthcare Practice Management Platform
Healthcare practice management platform Tebra secures $250 million in growth financing led by Hildred Capital for AI-driven automation.
Harmattan AI Raises $200M Series B | Defense Tech Unicorn at $1.4B Valuation
French defense tech company Harmattan AI secures $200 million Series B led by Dassault Aviation, reaching unicorn status.
AirNexis Therapeutics Raises $200M Series A | Novel COPD Treatment
Biotech AirNexis Therapeutics emerges from stealth with $200 million Series A for dual PDE3/4 inhibitor COPD therapy.
Turn your sales ideas into reality today
Start your 14-day Pro trial today. No credit card required.
Start building for free